Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-11

AUTHORS

David Strosberg, Eric B. Schneider, Jill Onesti, Neil Saunders, Bhavana Konda, Manisha Shah, Mary Dillhoff, Carl R. Schmidt, Lawrence A. Shirley

ABSTRACT

PURPOSE: The objective of this study was to investigate the prognostic impact of the biomarker serum pancreastatin in patients with metastatic neuroendocrine tumors (NETs) treated with transarterial chemoembolization (TACE). METHODS: Patients with metastatic NET treated with TACE at a single institution from 2000 to 2013 were analyzed. Patient demographics, response to therapy, and long-term survival were compared with baseline pancreastatin level and changes in pancreastatin levels after TACE. RESULTS: A total of 188 patients underwent TACE during the study period. An initial pancreastatin level greater than 5000 pg/mL correlated with worse overall survival (OS) from time of first TACE (median OS, 58.5 vs. 22.1 months, p < 0.001). A decrease in pancreastatin level by 50% or more after TACE treatment correlated with improved OS (median OS 53.8 vs. 29.9 months, p = 0.032). Patients with carcinoid syndrome were more likely to have a subsequent increase in pancreastatin after initial drop post-TACE (78.1 vs. 55.2%, p = 0.002). Patients with an increase in pancreastatin levels after initial drop post-TACE were more likely to have liver progression on imaging (70.7 vs. 40.7%, p = 0.005) and more likely to need repeat TACE (21.1 vs. 6.7%, p = 0.009). CONCLUSIONS: For patients with liver metastases from NET treated with TACE, pancreastatin measurement may be a useful prognostic indicator. Extreme high levels before TACE can predict poor outcomes, whereas significant drops in pancreastatin after TACE correlate with improved survival. An increase in levels after initial decrease may predict progressive liver disease requiring repeat TACE. As such, pancreastatin levels should be measured throughout the TACE treatment period. More... »

PAGES

3613-3620

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-018-6741-x

DOI

http://dx.doi.org/10.1245/s10434-018-6741-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1106646446

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30182331


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strosberg", 
        "givenName": "David", 
        "id": "sg:person.0763351343.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763351343.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schneider", 
        "givenName": "Eric B.", 
        "id": "sg:person.01355010037.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355010037.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mercy Health", 
          "id": "https://www.grid.ac/institutes/grid.428829.d", 
          "name": [
            "Mercy Health Grand Rapids, Grand Rapids, MI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Onesti", 
        "givenName": "Jill", 
        "id": "sg:person.01217415404.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217415404.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Emory University", 
          "id": "https://www.grid.ac/institutes/grid.189967.8", 
          "name": [
            "Emory University School of Medicine, Atlanta, GA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saunders", 
        "givenName": "Neil", 
        "id": "sg:person.01322546650.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322546650.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Konda", 
        "givenName": "Bhavana", 
        "id": "sg:person.01253410060.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253410060.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Manisha", 
        "id": "sg:person.010352322052.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010352322052.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dillhoff", 
        "givenName": "Mary", 
        "id": "sg:person.01355627661.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355627661.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schmidt", 
        "givenName": "Carl R.", 
        "id": "sg:person.01242005700.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242005700.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Ohio State University Wexner Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412332.5", 
          "name": [
            "Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shirley", 
        "givenName": "Lawrence A.", 
        "id": "sg:person.01002500642.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002500642.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6605618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005779365", 
          "https://doi.org/10.1038/sj.bjc.6605618"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605618", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005779365", 
          "https://doi.org/10.1038/sj.bjc.6605618"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0936-6555(97)80132-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011940748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-014-3728-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012545543", 
          "https://doi.org/10.1245/s10434-014-3728-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-0115(00)00167-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015101573"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-012-2786-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016553878", 
          "https://doi.org/10.1245/s10434-012-2786-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11605-007-0089-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020348445", 
          "https://doi.org/10.1007/s11605-007-0089-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mpa.0000000000000030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021193370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mpa.0000000000000030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021193370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jamcollsurg.2015.12.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022388006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9610(98)00042-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022483984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19930415)71:8<2624::aid-cncr2820710830>3.0.co;2-b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027787961"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/02841868709113712", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027884281"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-010-9750-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029271427", 
          "https://doi.org/10.1007/s12032-010-9750-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mpa.0000000000000572", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033230866"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mpa.0000000000000572", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033230866"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mpa.0b013e3181c68d7a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044696997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mpa.0b013e3181c68d7a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044696997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mpa.0b013e3181c68d7a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044696997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.21389", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047624223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.21389", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047624223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.12.142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2214/ajr.06.0933", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069298201"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00330-002-1558-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075222278", 
          "https://doi.org/10.1007/s00330-002-1558-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/107327480601300110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077195493"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/107327480601300110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077195493"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-11", 
    "datePublishedReg": "2018-11-01", 
    "description": "PURPOSE: The objective of this study was to investigate the prognostic impact of the biomarker serum pancreastatin in patients with metastatic neuroendocrine tumors (NETs) treated with transarterial chemoembolization (TACE).\nMETHODS: Patients with metastatic NET treated with TACE at a single institution from 2000 to 2013 were analyzed. Patient demographics, response to therapy, and long-term survival were compared with baseline pancreastatin level and changes in pancreastatin levels after TACE.\nRESULTS: A total of 188 patients underwent TACE during the study period. An initial pancreastatin level greater than 5000\u00a0pg/mL correlated with worse overall survival (OS) from time of first TACE (median OS, 58.5 vs. 22.1\u00a0months, p\u2009<\u20090.001). A decrease in pancreastatin level by 50% or more after TACE treatment correlated with improved OS (median OS 53.8 vs. 29.9\u00a0months, p\u2009=\u20090.032). Patients with carcinoid syndrome were more likely to have a subsequent increase in pancreastatin after initial drop post-TACE (78.1 vs. 55.2%, p\u2009=\u20090.002). Patients with an increase in pancreastatin levels after initial drop post-TACE were more likely to have liver progression on imaging (70.7 vs. 40.7%, p\u2009=\u20090.005) and more likely to need repeat TACE (21.1 vs. 6.7%, p\u2009=\u20090.009).\nCONCLUSIONS: For patients with liver metastases from NET treated with TACE, pancreastatin measurement may be a useful prognostic indicator. Extreme high levels before TACE can predict poor outcomes, whereas significant drops in pancreastatin after TACE correlate with improved survival. An increase in levels after initial decrease may predict progressive liver disease requiring repeat TACE. As such, pancreastatin levels should be measured throughout the TACE treatment period.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1245/s10434-018-6741-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "name": "Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors", 
    "pagination": "3613-3620", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "af390076876e6c96dd61ab62fb4b3a53743fcc424ed9c098d8f5328b345d84bc"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30182331"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-018-6741-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1106646446"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-018-6741-x", 
      "https://app.dimensions.ai/details/publication/pub.1106646446"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000571.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1245%2Fs10434-018-6741-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-018-6741-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-018-6741-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-018-6741-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-018-6741-x'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      21 PREDICATES      48 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-018-6741-x schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nbeaeacda4b8b48f6860f46e1a0caae59
4 schema:citation sg:pub.10.1007/s00330-002-1558-0
5 sg:pub.10.1007/s11605-007-0089-z
6 sg:pub.10.1007/s12032-010-9750-6
7 sg:pub.10.1038/sj.bjc.6605618
8 sg:pub.10.1245/s10434-012-2786-4
9 sg:pub.10.1245/s10434-014-3728-0
10 https://doi.org/10.1002/1097-0142(19930415)71:8<2624::aid-cncr2820710830>3.0.co;2-b
11 https://doi.org/10.1002/cncr.21389
12 https://doi.org/10.1016/j.jamcollsurg.2015.12.014
13 https://doi.org/10.1016/s0002-9610(98)00042-7
14 https://doi.org/10.1016/s0167-0115(00)00167-1
15 https://doi.org/10.1016/s0936-6555(97)80132-x
16 https://doi.org/10.1097/mpa.0000000000000030
17 https://doi.org/10.1097/mpa.0000000000000572
18 https://doi.org/10.1097/mpa.0b013e3181c68d7a
19 https://doi.org/10.1177/107327480601300110
20 https://doi.org/10.1200/jco.2003.12.142
21 https://doi.org/10.2214/ajr.06.0933
22 https://doi.org/10.3109/02841868709113712
23 schema:datePublished 2018-11
24 schema:datePublishedReg 2018-11-01
25 schema:description PURPOSE: The objective of this study was to investigate the prognostic impact of the biomarker serum pancreastatin in patients with metastatic neuroendocrine tumors (NETs) treated with transarterial chemoembolization (TACE). METHODS: Patients with metastatic NET treated with TACE at a single institution from 2000 to 2013 were analyzed. Patient demographics, response to therapy, and long-term survival were compared with baseline pancreastatin level and changes in pancreastatin levels after TACE. RESULTS: A total of 188 patients underwent TACE during the study period. An initial pancreastatin level greater than 5000 pg/mL correlated with worse overall survival (OS) from time of first TACE (median OS, 58.5 vs. 22.1 months, p < 0.001). A decrease in pancreastatin level by 50% or more after TACE treatment correlated with improved OS (median OS 53.8 vs. 29.9 months, p = 0.032). Patients with carcinoid syndrome were more likely to have a subsequent increase in pancreastatin after initial drop post-TACE (78.1 vs. 55.2%, p = 0.002). Patients with an increase in pancreastatin levels after initial drop post-TACE were more likely to have liver progression on imaging (70.7 vs. 40.7%, p = 0.005) and more likely to need repeat TACE (21.1 vs. 6.7%, p = 0.009). CONCLUSIONS: For patients with liver metastases from NET treated with TACE, pancreastatin measurement may be a useful prognostic indicator. Extreme high levels before TACE can predict poor outcomes, whereas significant drops in pancreastatin after TACE correlate with improved survival. An increase in levels after initial decrease may predict progressive liver disease requiring repeat TACE. As such, pancreastatin levels should be measured throughout the TACE treatment period.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N552d06c2faa84adfb216d503259a228b
30 Na7de1044673f4e558f42ebdcb2dfbebc
31 sg:journal.1105545
32 schema:name Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors
33 schema:pagination 3613-3620
34 schema:productId N257475822165412d871d7a279e5af4aa
35 N5bcca61457c7417b8a17a45c5b7330f8
36 N5d292140f2e74990bb5abc37752faa75
37 N653c11afd9c448d99703d69f52a0c854
38 Ncc7b16db518e42e09e84b2a46402d891
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106646446
40 https://doi.org/10.1245/s10434-018-6741-x
41 schema:sdDatePublished 2019-04-11T00:26
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher N3dc6fd8680cd4b26a6513ac9e3be30f8
44 schema:url https://link.springer.com/10.1245%2Fs10434-018-6741-x
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N040d73a5482040f791a19da231ddf99d rdf:first sg:person.01002500642.01
49 rdf:rest rdf:nil
50 N12f399bbd17b411d8188eea1cbd5eda6 rdf:first sg:person.010352322052.44
51 rdf:rest Na263034ce3f244159bb4a75f22e683ce
52 N257475822165412d871d7a279e5af4aa schema:name dimensions_id
53 schema:value pub.1106646446
54 rdf:type schema:PropertyValue
55 N3dc6fd8680cd4b26a6513ac9e3be30f8 schema:name Springer Nature - SN SciGraph project
56 rdf:type schema:Organization
57 N48c1499d35fa47d9bc70754b1c808bf3 rdf:first sg:person.01355010037.41
58 rdf:rest Nc02198a2f5904773ab4a48471c80118b
59 N552d06c2faa84adfb216d503259a228b schema:issueNumber 12
60 rdf:type schema:PublicationIssue
61 N5bcca61457c7417b8a17a45c5b7330f8 schema:name readcube_id
62 schema:value af390076876e6c96dd61ab62fb4b3a53743fcc424ed9c098d8f5328b345d84bc
63 rdf:type schema:PropertyValue
64 N5d292140f2e74990bb5abc37752faa75 schema:name pubmed_id
65 schema:value 30182331
66 rdf:type schema:PropertyValue
67 N653c11afd9c448d99703d69f52a0c854 schema:name nlm_unique_id
68 schema:value 9420840
69 rdf:type schema:PropertyValue
70 N686ef43c9ac64124a976ae9110be86bf rdf:first sg:person.01242005700.28
71 rdf:rest N040d73a5482040f791a19da231ddf99d
72 N8e5ed7bf6fff4f658a34226342128490 rdf:first sg:person.01253410060.46
73 rdf:rest N12f399bbd17b411d8188eea1cbd5eda6
74 Na263034ce3f244159bb4a75f22e683ce rdf:first sg:person.01355627661.41
75 rdf:rest N686ef43c9ac64124a976ae9110be86bf
76 Na7de1044673f4e558f42ebdcb2dfbebc schema:volumeNumber 25
77 rdf:type schema:PublicationVolume
78 Nbeaeacda4b8b48f6860f46e1a0caae59 rdf:first sg:person.0763351343.15
79 rdf:rest N48c1499d35fa47d9bc70754b1c808bf3
80 Nc02198a2f5904773ab4a48471c80118b rdf:first sg:person.01217415404.24
81 rdf:rest Neabb1c9739564b62923252b8a040d70d
82 Ncc7b16db518e42e09e84b2a46402d891 schema:name doi
83 schema:value 10.1245/s10434-018-6741-x
84 rdf:type schema:PropertyValue
85 Neabb1c9739564b62923252b8a040d70d rdf:first sg:person.01322546650.65
86 rdf:rest N8e5ed7bf6fff4f658a34226342128490
87 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
88 schema:name Medical and Health Sciences
89 rdf:type schema:DefinedTerm
90 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
91 schema:name Clinical Sciences
92 rdf:type schema:DefinedTerm
93 sg:journal.1105545 schema:issn 1068-9265
94 1534-4681
95 schema:name Annals of Surgical Oncology
96 rdf:type schema:Periodical
97 sg:person.01002500642.01 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
98 schema:familyName Shirley
99 schema:givenName Lawrence A.
100 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002500642.01
101 rdf:type schema:Person
102 sg:person.010352322052.44 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
103 schema:familyName Shah
104 schema:givenName Manisha
105 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010352322052.44
106 rdf:type schema:Person
107 sg:person.01217415404.24 schema:affiliation https://www.grid.ac/institutes/grid.428829.d
108 schema:familyName Onesti
109 schema:givenName Jill
110 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217415404.24
111 rdf:type schema:Person
112 sg:person.01242005700.28 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
113 schema:familyName Schmidt
114 schema:givenName Carl R.
115 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242005700.28
116 rdf:type schema:Person
117 sg:person.01253410060.46 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
118 schema:familyName Konda
119 schema:givenName Bhavana
120 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253410060.46
121 rdf:type schema:Person
122 sg:person.01322546650.65 schema:affiliation https://www.grid.ac/institutes/grid.189967.8
123 schema:familyName Saunders
124 schema:givenName Neil
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322546650.65
126 rdf:type schema:Person
127 sg:person.01355010037.41 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
128 schema:familyName Schneider
129 schema:givenName Eric B.
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355010037.41
131 rdf:type schema:Person
132 sg:person.01355627661.41 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
133 schema:familyName Dillhoff
134 schema:givenName Mary
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355627661.41
136 rdf:type schema:Person
137 sg:person.0763351343.15 schema:affiliation https://www.grid.ac/institutes/grid.412332.5
138 schema:familyName Strosberg
139 schema:givenName David
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0763351343.15
141 rdf:type schema:Person
142 sg:pub.10.1007/s00330-002-1558-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075222278
143 https://doi.org/10.1007/s00330-002-1558-0
144 rdf:type schema:CreativeWork
145 sg:pub.10.1007/s11605-007-0089-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1020348445
146 https://doi.org/10.1007/s11605-007-0089-z
147 rdf:type schema:CreativeWork
148 sg:pub.10.1007/s12032-010-9750-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029271427
149 https://doi.org/10.1007/s12032-010-9750-6
150 rdf:type schema:CreativeWork
151 sg:pub.10.1038/sj.bjc.6605618 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005779365
152 https://doi.org/10.1038/sj.bjc.6605618
153 rdf:type schema:CreativeWork
154 sg:pub.10.1245/s10434-012-2786-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016553878
155 https://doi.org/10.1245/s10434-012-2786-4
156 rdf:type schema:CreativeWork
157 sg:pub.10.1245/s10434-014-3728-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012545543
158 https://doi.org/10.1245/s10434-014-3728-0
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1002/1097-0142(19930415)71:8<2624::aid-cncr2820710830>3.0.co;2-b schema:sameAs https://app.dimensions.ai/details/publication/pub.1027787961
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1002/cncr.21389 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047624223
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/j.jamcollsurg.2015.12.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022388006
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/s0002-9610(98)00042-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022483984
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/s0167-0115(00)00167-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015101573
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/s0936-6555(97)80132-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011940748
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1097/mpa.0000000000000030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021193370
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1097/mpa.0000000000000572 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033230866
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1097/mpa.0b013e3181c68d7a schema:sameAs https://app.dimensions.ai/details/publication/pub.1044696997
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1177/107327480601300110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077195493
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1200/jco.2003.12.142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204031
181 rdf:type schema:CreativeWork
182 https://doi.org/10.2214/ajr.06.0933 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069298201
183 rdf:type schema:CreativeWork
184 https://doi.org/10.3109/02841868709113712 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027884281
185 rdf:type schema:CreativeWork
186 https://www.grid.ac/institutes/grid.189967.8 schema:alternateName Emory University
187 schema:name Emory University School of Medicine, Atlanta, GA, USA
188 rdf:type schema:Organization
189 https://www.grid.ac/institutes/grid.412332.5 schema:alternateName The Ohio State University Wexner Medical Center
190 schema:name Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA
191 Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA
192 rdf:type schema:Organization
193 https://www.grid.ac/institutes/grid.428829.d schema:alternateName Mercy Health
194 schema:name Mercy Health Grand Rapids, Grand Rapids, MI, USA
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...